The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics-Reference-Cited by-同舟云学术

The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics

Published:2024-05 Issue:10 Volume:84 Page:1932-1947.e10
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Yee Sook Wah,Macdonald Christian B.,Mitrovic Darko,Zhou Xujia,Koleske Megan L.,Yang Jia,Buitrago Silva Dina,Rockefeller Grimes Patrick,Trinidad Donovan D.,More Swati S.,Kachuri Linda,Witte John S.,Delemotte Lucie,Giacomini Kathleen M.,Coyote-Maestas Willow^ORCID

Publisher

Elsevier BV

Reference97 articles.

1. The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes;Kell;Molecules,2021

2. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?;Dobson;Nat. Rev. Drug Discov.,2008

3. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only;Kell;Drug Discov. Today,2011

4. A structure and evolutionary-based classification of solute carriers;Ferrada;iScience,2022

5. SLC transporters as therapeutic targets: emerging opportunities;Lin;Nat. Rev. Drug Discov.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two heads are better than one: Unravelling the potential Impact of Artificial Intelligence in nanotechnology;Nano TransMed;2024-12

2. Transport mechanism and structural pharmacology of human urate transporter URAT1;Cell Research;2024-09-09

3. Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood–Brain Barrier;Clinical Pharmacology & Therapeutics;2024-09-05